ketamine therapy
k

Johnson & Johnson’s $1.7 Billion Drug Success Signals Growth in Psychedelic Medicine Market

Johnson & Johnson’s Spravato, a nasal spray derived from ketamine, has reached blockbuster status with annual sales exceeding $1 billion. Approved in 2019 for...

Popular

Tensions Heighten Between the US and Iran Amid Escalating Regional Conflict

Military tensions between the United States and Iran have...

Trump Imposes 50% Tariffs on Canadian Imports

U.S. President Donald Trump has announced a 50% tariff...

RERUN: Former Aides Detail Internal Operations and Staff Accounts Within the Trump White House

This archival broadcast presents accounts from former officials and...

Student Protests in India Present Growing Political Challenge to Modi Government

Student demonstrations across India have raised questions regarding university...
spot_imgspot_imgspot_img
spot_imgspot_imgspot_imgspot_img